| Steven Patrick Thoma, MD | |
|
250 S Crescent Dr, Mason City, IA 50401-2926 | |
| (641) 494-5280 | |
| (641) 494-5281 |
| Full Name | Steven Patrick Thoma |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 12 Years |
| Location | 250 S Crescent Dr, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598021131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 44576 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Iowa Specialty Hospital - Belmond | Belmond, IA | Hospital |
| Kossuth Regional Health Center | Algona, IA | Hospital |
| Hansen Family Hospital | Iowa falls, IA | Hospital |
| Hancock County Health System | Britt, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Belmond Community Hospital | 1052201852 | 66 |
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.
KeyBridge Medical Revenue Management announced today that it has released the latest version of its proprietary online client services interface, iPortal.
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.
Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings.
› Verified 3 days ago
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.
KeyBridge Medical Revenue Management announced today that it has released the latest version of its proprietary online client services interface, iPortal.
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.
Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings.
› Verified 3 days ago
| Entity Name | Iowa Specialty Hospital- Clarion |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396760153 PECOS PAC ID: 3375451347 Enrollment ID: O20031120000622 |
News Archive
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.
KeyBridge Medical Revenue Management announced today that it has released the latest version of its proprietary online client services interface, iPortal.
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.
Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings.
› Verified 3 days ago
| Entity Name | Mason City Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043254055 PECOS PAC ID: 2860385572 Enrollment ID: O20040205001159 |
News Archive
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.
KeyBridge Medical Revenue Management announced today that it has released the latest version of its proprietary online client services interface, iPortal.
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.
Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings.
› Verified 3 days ago
| Entity Name | Belmond Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821122623 PECOS PAC ID: 1052201852 Enrollment ID: O20040316001360 |
News Archive
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.
KeyBridge Medical Revenue Management announced today that it has released the latest version of its proprietary online client services interface, iPortal.
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.
Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Patrick Thoma, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5400 | Steven Patrick Thoma, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5280 |
News Archive
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.
KeyBridge Medical Revenue Management announced today that it has released the latest version of its proprietary online client services interface, iPortal.
Teen girls who live in rural areas are more likely than their male counterparts to have undiagnosed asthma, and they often are at a higher risk of depression, according to researchers at the Medical College of Georgia at Georgia Regents University.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.
Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings.
› Verified 3 days ago
Dr. Christopher Edelen Adams, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5280 Fax: 641-494-5281 | |
Elizabeth Broghammer Takacs, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5280 | |
Dr. Timothy L Mulholland, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5280 Fax: 641-494-5281 | |
Dr. Steven H Schurtz, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-422-6700 Fax: 641-422-6679 | |
Dr. Paul S Macgregor, DO Urology Medicare: Not Enrolled in Medicare Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-422-6700 Fax: 641-422-6679 | |
Dr. Kevin R Rier, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5280 Fax: 641-494-5281 |